Indiplon

DB12590InvestigationalSmall molecule

Indiplon has been used in trials studying the treatment of Insomnia and Depression.

Mechanism: Pharmacologically active on Gamma-aminobutyric acid receptor subunit alpha-1
Curator reviewed
Formula / weight: C₂₀H₁₆N₄O₂S · 376.43 g/mol (avg)
Code names: NBI-34060

Resolves to

Compound

Structure

InChIKeyCBIAWPMZSFFRGN-UHFFFAOYSA-NSMILESCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C(=O)C1=CC=CS1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

669Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Indiplon, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.